MYCN

Amber Wolf1, Davide Leardini2, Lingzhi Li1

  • 1Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA.

Trends in molecular medicine
|September 24, 2025
PubMed
概括

瘤性MYCN蛋白通过重编程瘤代谢来驱动侵略性神经母细胞瘤. 这影响了瘤微环境和宿主因素,表明MYCN驱动的新陈代谢是治疗目标.